Release Date: 30/10/13 14:44 Summary: Notice of Annual General Meeting/Proxy Form Price Sensitive: No Download Document 482.08KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%